Emerging retatrutide, a twin -action treatment targeting equally GLP-1 and GIP receptors, is sparking considerable excitement within the weight loss community. Initial clinical studies have shown impressive decreases in physical size and gains in health markers for individuals with excess weight . Experts believe this novel approach has the potenti